Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

Further tests, such as CT scans and bone scans, may be performed to determine whether prostate cancer has spread. Management strategies for prostate cancer should be guided the severity of the ...

BBC presenter and former Scotland rugby star John Beattie has undergone a prostate examination live on air to encourage more men to get checked. The former British and Irish Lion had a rectal exam ...

Prostate cancer starts in the prostate gland, which is a part of a man's reproductive system. When it spreads to other parts of the body, like the jaw, it is called metastatic prostate cancer. But, ...

StockNews.com initiated coverage on shares of BeiGene (NASDAQ:BGNE – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the stock. Several other ...

In a first-of-its-kind unusual case, a doctor ‘transplanted’ cancer accidentally into his own body while performing surgery to remove a tumour from a 32-year-old patient who later died of ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

Melanoma, one of the most aggressive forms of skin cancer, often metastasizes to bones, causing severe bone loss, an increased risk of fractures, and significant pain. Bone metastasis is associated ...

M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer.

A recent study has uncovered the molecular mechanisms behind osteocyte death in melanoma bone metastasis, revealing that ferroptosis—an iron-dependent form of cell death—plays a central role in the ...

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.